Schedule 13D ownership disclosure
ABIVAX SA SPONSORED ADS
Ordinary Shares, par value EUR0.01 per share · CUSIP: 00370M103
Event date: 2026-01-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sofinnova Crossover I SLPReported CIK 0001845105
Shares: 6,399,478.00 · Class: 7.7%
- Sofinnova Partners SASReported CIK 0001574139
Shares: 6,399,478.00 · Class: 7.7%
- Antoine Papiernik
Shares: 6,399,478.00 · Class: 7.7%
- Cedric Moreau
Shares: 6,399,478.00 · Class: 7.7%
- Kinam Hong
Shares: 6,399,478.00 · Class: 7.7%
- Joseph Anderson
Shares: 6,399,478.00 · Class: 7.7%
- Jacques Theurillat
Shares: 6,399,478.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-003743
- Form type
- SCHEDULE 13D/A
- Filer
- Abivax S.A.
- CIK
- CIK 1956827
- Filed
- Jan 14, 2026
- Reporting period
- Jan 12, 2026
- Description
- Schedule 13D beneficial ownership